| Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment A Gupta, K Shah, MJ Oza, T Behl Biomedicine & Pharmacotherapy 109, 484-492, 2019 | 158 | 2019 |
| Leucas aspera: A review MS Prajapati, JB Patel, K Modi, MB Shah Pharmacognosy reviews 4 (7), 85, 2010 | 129 | 2010 |
| Traditional uses, phytochemistry and pharmacology of the medicinal species of the genus Cordia (Boraginaceae) MJOYA Kulkarni Journal of Pharmacy and Pharmacology 69 (7), 755-789, 2017 | 117 | 2017 |
| Formononetin treatment in type 2 diabetic rats reduces insulin resistance and hyperglycemia MJ Oza, YA Kulkarni Frontiers in pharmacology 9, 739, 2018 | 104 | 2018 |
| Biochanin A improves insulin sensitivity and controls hyperglycemia in type 2 diabetes MJ Oza, YA Kulkarni Biomedicine & Pharmacotherapy 107, 1119-1127, 2018 | 72 | 2018 |
| Formononetin attenuates kidney damage in type 2 diabetic rats MJ Oza, YA Kulkarni Life sciences 219, 109-121, 2019 | 61 | 2019 |
| SIRT1-FOXOs activity regulates diabetic complications MP Jalgaonkar, UM Parmar, YA Kulkarni, MJ Oza Pharmacological Research 175, 106014, 2022 | 57 | 2022 |
| ER stress response mediates diabetic microvascular complications H Sankrityayan, MJ Oza, YA Kulkarni, SR Mulay, AB Gaikwad Drug discovery today 24 (12), 2247-2257, 2019 | 47 | 2019 |
| Cyclin dependent kinase 5: A novel avenue for Alzheimer’s disease AS Bhounsule, LK Bhatt, KS Prabhavalkar, M Oza Brain research bulletin 132, 28-38, 2017 | 43 | 2017 |
| Formononetin ameliorates diabetic neuropathy by increasing expression of SIRT1 and NGF MJ Oza, YA Kulkarni Chemistry & biodiversity 17 (6), e2000162, 2020 | 36 | 2020 |
| Biological activities of meroterpenoids isolated from different sources NK Fuloria, RK Raheja, KH Shah, MJ Oza, YA Kulkarni, V Subramaniyan, ... Frontiers in Pharmacology 13, 830103, 2022 | 35 | 2022 |
| Novel therapeutic targets for epilepsy intervention L Kambli, LK Bhatt, M Oza, K Prabhavalkar Seizure 51, 27-34, 2017 | 35 | 2017 |
| Autophagy-nutrient sensing pathways in diabetic complications UM Parmar, MP Jalgaonkar, YA Kulkarni, MJ Oza Pharmacological research 184, 106408, 2022 | 34 | 2022 |
| Diabetes, diabetic complications, and flavonoids YA Kulkarni, MS Garud, MJ Oza, KH Barve, AB Gaikwad Fruits, vegetables, and herbs, 77-104, 2016 | 24 | 2016 |
| Role of dietary modifications in the management of type 2 diabetic complications MJ Oza, AP Laddha, AB Gaikwad, SR Mulay, YA Kulkarni Pharmacological Research 168, 105602, 2021 | 22 | 2021 |
| Trifolium pratense (Red Clover) Improve SIRT1 Expression and Glycogen Content in High Fat Diet‐Streptozotocin Induced Type 2 Diabetes in Rats MJ Oza, YA Kulkarni Chemistry & Biodiversity 17 (4), e2000019, 2020 | 20 | 2020 |
| Role of artificial intelligence in health care S Mishra, A Takke, S Auti, S Suryavanshi, M Oza BioChemistry: An Indian Journal 11 (5), 1-14, 2017 | 18 | 2017 |
| Comprehensive Review of Bioactive and Molecular Aspects of Moringa Oleifera Lam KH Shah, MJ Oza Food Reviews International 38 (7), 1427-1460, 2022 | 15 | 2022 |
| Gut-brain axis and neurological disorders-how microbiomes affect our mental health NY Bhatia, MP Jalgaonkar, AB Hargude, AP Sherje, MJ Oza, GM Doshi CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2023 | 14 | 2023 |
| Development and characterization of solid self-emulsifying drug delivery system containing nateglinide V Suvarna Asian Journal of Pharmaceutics (AJP) 11 (01), 2017 | 14 | 2017 |
